Cyclin D1, EMS1 and 11q13 amplification in breast cancer. - Wikidata - awgldk - TriplyDB

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

http://www.wikidata.org/entity/Q35130688

about

Cortactin signalling and dynamic actin networks Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling Net1 and Myeov: computationally identified mediators of gastric cancer EMSY links breast cancer gene 2 to the 'Royal Family'Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells.Therapeutic CDK4/6 inhibition in breast cancer: key mechanisms of response and failure.RSF1 and not cyclin D1 gene amplification may predict lack of benefit from adjuvant tamoxifen in high-risk pre-menopausal women in the MA.12 randomized clinical trial.BET domain co-regulators in obesity, inflammation and cancer Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent AFAP-110 is overexpressed in prostate cancer and contributes to tumorigenic growth by regulating focal contacts Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.High-resolution array CGH clarifies events occurring on 8p in carcinogenesis An eQTL-based method identifies CTTN and ZMAT3 as pemetrexed susceptibility markers.Centrosome clustering and cyclin D1 gene amplification in double minutes are common events in chromosomal unstable bladder tumors Minireview: Tipping the balance: ligand-independent activation of steroid receptors.Cortactin, another player in the Lyn signaling pathway, is over-expressed and alternatively spliced in leukemic cells from patients with B-cell chronic lymphocytic leukemia Inhibition of cyclin D1 expression by androgen receptor in breast cancer cells--identification of a novel androgen response element.Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.Essential gene profiles in breast, pancreatic, and ovarian cancer cells.Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis Estrogen receptor coregulators and pioneer factors: the orchestrators of mammary gland cell fate and development.SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.Cell cyclins: triggering elements of cancer or not?An EGFR-Src-Arg-cortactin pathway mediates functional maturation of invadopodia and breast cancer cell invasion.Stromal expression of β-arrestin-1 predicts clinical outcome and tamoxifen response in breast cancer.Cortactin: a multifunctional regulator of cellular invasiveness Overexpression of Grb2-associated binder 2 in human lung cancer Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response.Novel patterns of genome rearrangement and their association with survival in breast cancer.Fibulin-4 is associated with tumor progression and a poor prognosis in ovarian carcinomas ANO1 (TMEM16A) in pancreatic ductal adenocarcinoma (PDAC)Contributions of Rad9 to tumorigenesis.Association of CTTN polymorphisms with the risk of colorectal cancer Biological effects of ray cartilage extract on human breast cancer cell line MCF-7 and its mechanism.Association between genetic polymorphisms in cortactin and susceptibility to gastric cancer.Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study Expression of cortactin and focal adhesion kinase in colorectal adenocarcinoma: correlation with clinicopathologic parameters and their prognostic implication Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.Regulation of the actin cytoskeleton in cancer cell migration and invasion.

P2860

Q24528115-864093B7-065A-4185-9C56-858C5C484FEF Q24555819-48B4E8DB-E8F5-430C-962C-72EB0AE14905 Q24602862-AB40A159-B155-492A-A9D8-904DF057415F Q24651842-228E5713-A465-450A-92F2-8BBD343B7EE2 Q24806435-639E71BA-251A-424C-8198-753496DE4702 Q25257824-E7AD40D3-3476-4B19-8AEC-3B58E5AB36B3 Q27851564-05FAD68E-FD1E-4B2A-B754-8F15E916979B Q27852757-776A268D-7523-485C-92BC-C5800C9EF87C Q28269301-00BF2225-B5FA-48E6-9363-74F37B723E65 Q28283260-D54AC8FD-72F3-4B7D-8740-A1BCDBB8F067 Q28396630-A60EC74A-83A1-45F4-B3EE-178B2ED475D7 Q33260375-2B14AA0F-CEEA-44BF-AA03-D08D9B3D263A Q33374399-675EA15F-9930-43C5-9E6E-D1FE0EEF16E0 Q33398764-CBE69A23-0F07-4DF8-93AC-213DB191B7A1 Q33601875-35923C90-6233-4186-BFC8-88FAE02796C9 Q33631775-999AAA12-4B9E-4DDB-A4FA-33BE46D3A3AB Q33695977-A322BCD9-FDA4-46D4-8D92-A4127A94CA5C Q34122589-FF8BB6E4-794D-41D1-95CA-DBE5E5EF00EB Q34190232-FDFB7DBD-BC9D-4F76-8806-24C20685722A Q34268870-1FAA9807-618C-4361-985D-0CDDEDF77A1B Q34389482-A4D5BF2B-E2F2-492F-A8DE-57A48F5F134B Q34391427-DF3618B7-54EC-48D0-96DE-93FF71C37B1E Q34452617-990D78F9-72C8-4E81-A4EC-92B11DB376CA Q34467866-399A0759-97E9-4911-9EE1-64903987513A Q34670759-573F4DE5-065E-4544-A7C6-1D97BF49264A Q34801160-F7FC34F4-0C0A-4489-8F09-2FFE4E704767 Q34891306-4A41FD57-94F8-4CAE-BF38-8F67E09ED0D7 Q34940929-B38DFE1B-895D-492F-8877-76740B5BE8BE Q35100037-A25D1AFF-0C6A-4EA5-A9EC-0549B07CC3F7 Q35173695-3DA42DEE-A100-4C4C-9C38-561D7559C37F Q35177014-CA2DCB0B-3418-4630-9CCE-6C86C15A3212 Q35233202-9DEAE74E-D1A3-4727-A704-4C6CEAE3060C Q35691004-836FF472-DB45-4574-8EFD-06994AF993B7 Q35803448-26B39B08-3442-497F-9694-D75136E20F1C Q35870797-7F40FC2E-6D8F-4573-909B-CB033C58568D Q35897689-7BF138EB-90F4-442E-B1F2-1BC0AD150A6F Q36245589-9DF01C08-4FBF-4E67-8779-6D69407E592E Q36374631-43B896A0-24F8-4620-BEE5-6C5BE7E499FF Q36503782-CA177DBF-2E53-47FD-AABE-9ACFFD9CEDA6 Q36574131-42CFADAA-FEBB-414A-B25D-B548AB735FAA

P2860

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

http://www.wikidata.org/entity/Q35130688

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@ast

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@en

type

label

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@ast

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@en

prefLabel

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@ast

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@en

P1433

Q35130688-6F5ED1E3-CD96-48F3-ACB2-7CC254FD84A4

P1476

Q35130688-7AB8BF89-B4AE-4FED-9443-233957EDEF3A

P2093

Q35130688-44897D60-BCEA-4703-B766-6E232EC79C46

Q35130688-610123E2-7F5A-4097-BEB6-0684BDC23B2F

Q35130688-865659B9-5E6B-4039-A25F-DAF1E49A9BF5

Q35130688-BA1E6A04-F022-4866-B8D0-BF10D0730335

Q35130688-BC939362-73ED-4EFF-873E-9A541752A66F

P2860

Q35130688-18F780C8-FF9B-4AA3-AD81-8AF651F86FD3

Q35130688-395FCC18-0EB1-42D3-83CC-8635D3F1BEF9

Q35130688-50D035B8-9ED3-4C75-BFAF-2F2C6EB269FB

Q35130688-680D496E-EE35-4DF3-8C9F-C4D6B53D6EE1

Q35130688-6B49CBC6-D5A2-4528-9314-253E58AC79D7

Q35130688-6EB759B5-97A2-4758-A4B1-E7515D31961D

Q35130688-7451A0A3-F828-454D-86E7-B5F3651AFAD3

Q35130688-843EEA74-DA63-4FE5-BDB2-3348E54B8ACB

Q35130688-B94E308B-F485-4FCE-B99B-D282F8F28072

Q35130688-F7A40C51-E8F8-460A-B83C-B48E65C1692F

P2888

Q35130688-ACE5EC69-041A-4804-9787-AE887312E159

P304

Q35130688-CA442186-4CA8-49B4-B27F-4EF24A25171C

P31

Q35130688-26FB1CDA-1A5A-4E8D-9D81-5F71355A0434

P356

Q35130688-C239B79F-2124-46B7-B081-C1A5C6538632

P407

Q35130688-D64F55B9-52D0-4CFF-ACAD-C6D224B04DFB

P433

Q35130688-43CEA932-C4D2-43D3-AB43-951CCD7C9161

P478

Q35130688-466AB454-A6E0-46C1-891F-3C635313466E

P577

Q35130688-AE5AAEED-77CE-4B6E-875B-EF0CAA4D79DF

P6179

Q35130688-B72FDE84-6935-443F-9DB9-97CD121B7554

P698

Q35130688-D96DBCC9-2E9D-45E0-A33D-10401A6C927B

P356

A:1023033708204

P1433

Breast Cancer Research and Treatment

P1476

Cyclin D1, EMS1 and 11q13 amplification in breast cancer.

@en

P2093

Christopher J Ormandy

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Musgrove

http://www.w3.org/2001/XMLSchema#string

Rina Hui

http://www.w3.org/2001/XMLSchema#string

Robert L Sutherland

http://www.w3.org/2001/XMLSchema#string

Roger J Daly

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons

The product of the EMS1 gene, amplified and overexpressed in human carcinomas, is homologous to a v-src substrate and is located in cell-substratum contact sites

Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4

Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1

Gene expression and cell cycle arrest mediated by transcription factor DMP1 is antagonized by D-type cyclins through a cyclin-dependent-kinase-independent mechanism

Identification and characterization of a novel cytoskeleton-associated pp60src substrate.

Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis

Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.

Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.

Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors.

P2888

a:1023033708204

P304

323-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1023/A:1023033708204

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1028239866

http://www.w3.org/2001/XMLSchema#string

P698

12755491

http://www.w3.org/2001/XMLSchema#string